ALNY — ALNYLAM PHARMACEUTICALS, INC.
Nasdaq ·
Materials ·
Chemicals ·
CIK 1178670 ·
Last close
$295.05
52W High
$495.55
52W Low
$250.35
ADV30
1,108,387
Last filing
2026-04-30
SIC
2834
No quarterly fundamentals indexed for this ticker.
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$714,896,000
Investing CF
$297,018,000
Financing CF
$-335,558,000
CapEx
$-71,560,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$3.66
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-6,496,533,000
Inventory
$84,025,000
Receivables
$883,957,000
ST Investments
$1,298,444,000
EBIT TTM
$869,668,000
Pretax Income TTM
$586,401,000
Interest Exp TTM
$283,267,000
Analysts
25
Yahoo Snapshot (yfinance, live)
Total Revenue
$4,286,923,008
EBITDA
$806,942,976
Free Cash Flow
$204,714,128
Enterprise Value
$39,353,892,864
Total Cash
$3,009,222,912
Total Debt
$2,970,230,016
Shares Out
133,512,573
Trailing EPS
$3.98
Book Value
$8.06
ROE
90.4%
ROA
10.1%
Div Yield
—
Recent Insider Activity
No insider activity indexed for this ticker.